Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2013

Jul 1, 2013

31676_dirs_2013-07-01_4c46614c-daf9-46ac-8ff2-0095f367581c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2013-06-19

Reporting Person: MERIDIAN VENTURE PARTNERS II LP (10% Owner)
Reporting Person: Meridian Venture Partners II GP, L.P. (10% Owner)
Reporting Person: Meridian Venture Partners II, Co. (10% Owner)